Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report.
Metadata only so far. Questions are answered only with quotes from this document. Source: OpenAlex, Europe PMC, retrieved 2026-11-05.
Record metadata
- Journal
- Front Oncol
- Date
- 2023-04-06
- Citations
- 8
- Type
- article
- License
- cc by
Not in the data yet: a study card. A one-glance card (population, design, endpoints, result, each tied to a quote) is not built yet. The fields above are registry or bibliographic metadata, not quotes.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you get that instead of a guess.
Source text
No passages are loaded for this document yet.